Shire PLC (LSE:SHP) - Share price - Overview

Stock Report

Shire PLC SHP

Last Price
GBX4,844.00

Day Change
-84.00|-1.70%

As of 24/02/2017
17:07:01 GMT | GBX
Minimum 15 Minutes Delay.

Last Close4,928.00p
Day Range4,838.00 - 4,944.50
Mkt Cap43.80Bil
52-Wk Range2,707.19 - 5,377.00
Yield %0.39
ISINJE00B2QKY057
Volume2,022,614
P/E29.90
P/S6.60
P/CF18.13

Share Price

Total Returns 24/02/2017

 Chg (%)  
More ...
Shire PLC10.95 
FTSE 100 TR GBP2.45
 
Financials
201420152016
More ...
Income Statement
Turnover3,664.344,331.22-
Operating Profit1,033.20958.15-
Net Profit1,995.88904.29-
Reported EPS337.83152.21-
Balance Sheet
Current Assets3,330.061,522.44-
Non Current Assets5,428.359,689.03-
Total Assets8,758.4011,211.48-
Current Liabilities1,941.522,501.59-
Total Liabilities3,192.634,576.92-
Total Equity5,565.776,634.56-
Cash Flow
Operating Cash Flow2,572.911,577.46-
Net Change in Cash457.76-1,919.61-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20174,813.99434.01167.9211.160.0732.720.68
20185,426.78504.8216.319.600.5948.181.00

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
22/02/2017PurchaseMr. Albert Stroucken4,834.405,250253,806.00
22/02/2017PurchaseMr. Albert Stroucken4,832.541,50072,488.00
22/02/2017PurchaseMr. Albert Stroucken4,837.0797847,307.00
22/02/2017PurchaseMr. Albert Stroucken4,827.4614,109681,107.00

Company Profile

Shire PLC is a biotech company. The Company is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines for patients with rare diseases and other select conditions.

Sector

Biotechnology

Market Position

15 of 1853 Companies

Index

FTSE 100 ,FTSE 350 ,S&P Europe 350 ,Eurotop 300 ,FTSE All Share

Outlook

(16/02/2017) ceo - "We remain extremely optimistic about long-term growth prospects"

Next Event 09/03/2017

Ex Dividend
Ratios
CompSecMkt
More ...
PER (E)10.8914.3416.13
Div Yld (E)0.723.764.10
PEG (E)0.09-0.431.08
ROCE0.00202.62104.73
Op Mrgn0.00-9.81-16.30
EPS Grwth119.0743.0235.18
Dividends
PreviousLatest
More ...
Record Date09/09/1610/03/17
Ex-Div08/09/1609/03/17
Paid07/10/1625/04/17
Amnt3.5120.64

Broker Sentiment

Strong Buy0
Buy4
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMrs. Susan Kilsby
Chief Executive OfficerDr. Flemming Ornskov
Chief Financial OfficerMr. Jeff Poulton
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.